Burlingame, Feb. 15, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global uveitis treatment market is estimated to be valued at US$ 710.0 million in 2022 and is expected to exhibit a CAGR of 5.3% during the forecast period (2022-2030).
Key Trends and Analysis of the Global Uveitis Treatment Market:
Major players operating in the market are focusing on adopting strategies such as product launch, which is expected to drive the market growth over the forecast period. For instance, on March 28, 2022 Bausch Health Companies Inc. Canadian multinational specialty pharmaceutical company which develops, manufactures and markets pharmaceutical products and branded generic drugs, primarily for skin diseases, gastrointestinal disorders, eye health and neurology, announced the U.S. commercial launch of xipere (Triamcinolone Acetonide Injectable Suspension) for suprachoroidal use for the treatment of macular edema associated with uveitis.
Request Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/1094
Key Market Takeaways:
The global uveitis treatment market is expected to exhibit a CAGR of 5.3% during the forecast period due to increasing prevalence of anterior uveitis. For instance, on August 12, 2021, Cipla Limited announced that it received final approval for its Abbreviated New Drug Application (ANDA) for Difluprednate Ophthalmic Emulsion 0.05% from the U.S. Food and Drug Administration. Durezol is used to treat endogenous anterior uveitis and inflammation and pain associated with ocular surgery.
Among treatment type, corticosteroids segment is expected to hold a dominant position over the forecast period, owing to increased use of corticosteroids in treatment of uveitis. For instance, according to National Health Services UK steroid medicine, steroid injection steroid eye drops and Steroids tablets or capsules are the main treatments. Most cases of uveitis can be treated with steroid medicine. A medicine called prednisolone a drug belonging to class of corticosteroids is usually used.
On the basis of disease type, anterior uveitis segment is expected to hold a dominant position over the forecast period, owing to increasing prevalence of disease. For instance, according to the study, ‘Epidemiology of uveitis in urban Australia’, published in April 2019 in the journal Clinical and Experimental Ophthalmology, the distribution of prevalent uveitis cases was anterior (75%), intermediate (6%), posterior (15%) and pan uveitis (4%).
Competitive Landscape:
Key players operating in the global uveitis treatment market include AbbVie, Novartis AG, Bausch Health Companies Inc., Galapagos NV, EyePoint Pharmaceuticals, Inc., Clearside Biomedical, Tarsier Pharma Ltd, Santen Pharmaceutical Co., Ltd., Bausch & Lomb Incorporated, Sanofi Regeneron Pharmaceuticals, Inc., and Alimera Sciences
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/1094
Market Segmentation:
- Global Uveitis Treatment Market, By Treatment Type:
- Corticosteroids
- Immunosuppressant
- Monoclonal Antibodies
- Cycloplegic Agents
- Antibiotics
- Antivirals
- Antifungal
- Analgesics
- Global Uveitis Treatment Market, By Disease Type:
- Anterior Uveitis
- Posterior Uveitis
- Intermediate Uveitis
- Pan uveitis
- Global Uveitis Treatment Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
- Global Uveitis Treatment Market, By Region:
- North America
- By Country
- U.S.
- Canada
- By Country
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Country
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Country
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Country
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- By Country
- Africa
- By Region/Country
- South Africa
- Central Africa
- North Africa
- By Region/Country
- North America
Related Market Intelligence Reports:
Dental Laser Market, By Product Type (Soft Tissue Dental Lasers and All Tissue Dental Laser), By Application (Conservative Dentistry, Endodontic Treatment, Periodontics, Oral Surgery, Implantology, Peri-Implantitis, Tooth Whitening, and Others), By End User (Hospitals, Dental Clinics, and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2023 – 2030
Ontogenetic Market, By Light Equipment (Laser and Light-emitting Diode (LED)), By Actuator (Channelrhodopsin, Halorhodopsin, and Archaerhodopsin), By Sensor (Calcium (Aequorin, Cameleon, and Other Calcium Sensors), Chloride (Clomeleon), Membrane-gated (Mermaid), and Other Sensors), By Application (Neuroscience, Behavioral, Tracking, Retinal Disease Treatment, and Other Applications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2028
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
